SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical
Indications -- Hepatitis
An SI Board Since March 2001
Posts SubjectMarks Bans
312 28 0
Emcee:  tuck Type:  Unmoderated
Introduction Compact
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsPosted
162Prevalence of Chronic HBV Infection: investorshub.comDewDiligence_on_SI-11/28/2006
161HCV vs HIV Deaths, 1985-2020: investorshub.comDewDiligence_on_SI-11/12/2006
160Pharmasset Initiates Phase-1 Study of R7128 for HCV: investorshub.comDewDiligence_on_SI-10/31/2006
159Achillion IPO’s below expected range: investorshub.comDewDiligence_on_SI-10/25/2006
158[Hepatitis C virus replicates in the liver of patients who have a sustained resptuck-10/24/2006
157A post about the FDA panel that met recently to recommend regulatory guidelines tuck-10/23/2006
156GILD has a new non-nucleoside HCV polymerase inhibitor called GS9190: investorsDewDiligence_on_SI-10/18/2006
155Roche Begins Phase-2 for HCV Polymerase Inhibitor: investorshub.comDewDiligence_on_SI-10/13/2006
154HGSI Details Albuferon Phase-3 Program: investorshub.comDewDiligence_on_SI-10/4/2006
153HCV Treatment Paradigms 1989-2015: investorshub.comDewDiligence_on_SI-9/30/2006
152Telbivudine Approved in Switzerland for Chronic Hepatitis B: investorshub.com DewDiligence_on_SI-9/21/2006
151BMY, Medivir AB (Sweden) Ink HIV Collaboration: investorshub.comDewDiligence_on_SI-9/13/2006
150Valeant’s Viramune Inferior to Ribavirin in HCV Efficacy: investorshub.comDewDiligence_on_SI-9/12/2006
149Overview of HCV Therapies in Development: tinyurl.comDewDiligence_on_SI-9/10/2006
148>>OT: DD, What are your thoughts on OSIP these days? TIA<< Very OT tuck-7/27/2006
147OT: DD, What are your thoughts on OSIP these days? TIASeachRE-7/27/2006
146VX-950 notes from VRTX CC: investorshub.comDewDiligence_on_SI-7/26/2006
145Oops—the server holding that image file is down for a software upgrade. Back up DewDiligence_on_SI-6/16/2006
144Telbivudine vs Hepsera graphic: investorshub.comDewDiligence_on_SI-6/15/2006
143Pretty pictures (HBV serum markers): investorshub.comDewDiligence_on_SI-6/13/2006
142Contemporaneous reaction to the Albuferon deal: Albuferon and IDIX’s NM283 are DewDiligence_on_SI-6/6/2006
141NVS, HGSI Ink Albuferon Deal for HCV: investorshub.comDewDiligence_on_SI-6/6/2006
140GNLB, NVS Ink HCV Drug-Discovery Collaboration: investorshub.comDewDiligence_on_SI-6/5/2006
139Quiz (high difficulty/tricky): What percent of treatment-naïve individuals DewDiligence_on_SI-5/31/2006
138Recommended (portion of) webcast on HCV therapy: corporate-ir.net [click on theDewDiligence_on_SI-5/28/2006
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News